Legacy Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Sell |
4,387
-8
| -0.2% | -$2.74K | 0.15% | 82 |
|
|
2026
Q1 | $1.55M | Sell |
4,395
-63
| -1% | -$22.5K | 0.18% | 69 |
|
|
2025
Q4 | $1.46M | Buy |
4,458
+210
| +5% | +$66.6K | 0.16% | 81 |
|
|
2025
Q3 | $1.2M | Buy |
+4,248
| New | +$1.23M | 0.15% | 88 |
|
|
2025
Q2 | – | Sell |
-8,843
| Closed | -$2.76M | – | 37 |
|
|
2025
Q1 | $2.76M | Buy |
8,843
+427
| +5% | +$126K | 0.28% | 68 |
|
|
2024
Q4 | $2.19M | Sell |
8,416
-1,011
| -11% | -$300K | 0.21% | 81 |
|
|
2024
Q3 | $3.04M | Buy |
9,427
+62
| +0.7% | +$20.3K | 0.33% | 60 |
|
|
2024
Q2 | $2.93M | Buy |
9,365
+370
| +4% | +$109K | 0.36% | 53 |
|
|
2024
Q1 | $2.56M | Sell |
8,995
-2,160
| -19% | -$632K | 0.32% | 60 |
|
|
2023
Q4 | $3.21M | Sell |
11,155
-3,021
| -21% | -$823K | 0.41% | 43 |
|
|
2023
Q3 | $3.81M | Sell |
14,176
-217
| -2% | -$54.2K | 0.61% | 34 |
|
|
2023
Q2 | $3.2M | Sell |
14,393
-295
| -2% | -$68.5K | 0.47% | 48 |
|
|
2023
Q1 | $3.55M | Buy |
14,688
+742
| +5% | +$182K | 0.65% | 37 |
|
|
2022
Q4 | $3.66M | Sell |
13,946
-138
| -1% | -$37K | 0.67% | 30 |
|
|
2022
Q3 | $3.17M | Buy |
14,084
+422
| +3% | +$102K | 0.7% | 25 |
|
|
2022
Q2 | $3.32M | Buy |
13,662
+2,136
| +19% | +$523K | 0.7% | 20 |
|
|
2022
Q1 | $2.79M | Buy |
11,526
+8,675
| +304% | +$1.99M | 0.54% | 29 |
|
|
2021
Q4 | $641K | Sell |
2,851
-130
| -4% | -$27.4K | 0.24% | 60 |
|
|
2021
Q3 | $634K | Buy |
2,981
+24
| +0.8% | +$5.52K | 0.25% | 58 |
|
|
2021
Q2 | $721K | Buy |
2,957
+18
| +0.6% | +$4.43K | 0.29% | 53 |
|
|
2021
Q1 | $731K | Sell |
2,939
-276
| -9% | -$65.9K | 0.32% | 49 |
|
|
2020
Q4 | $739K | Buy |
3,215
+17
| +0.5% | +$3.92K | 0.42% | 45 |
|
|
2020
Q3 | $813K | Buy |
3,198
+16
| +0.5% | +$3.96K | 0.54% | 38 |
|
|
2020
Q2 | $750K | Buy |
3,182
+8
| +0.3% | +$1.82K | 0.6% | 36 |
|
|
2020
Q1 | $643K | Sell |
3,174
-251
| -7% | -$54.8K | 0.64% | 41 |
|
|
2019
Q4 | $826K | Buy |
3,425
+266
| +8% | +$58.6K | 0.52% | 43 |
|
|
2019
Q3 | $611K | Buy |
3,159
+18
| +0.6% | +$3.46K | 0.46% | 51 |
|
|
2019
Q2 | $579K | Sell |
3,141
-4,093
| -57% | -$733K | 0.39% | 50 |
|
|
2019
Q1 | $1.37M | Buy |
7,234
+3,035
| +72% | +$580K | 0.45% | 53 |
|
|
2018
Q4 | $817K | Sell |
4,199
-7,054
| -63% | -$1.38M | 0.62% | 39 |
|
|
2018
Q3 | $2.33M | Buy |
11,253
+8,655
| +333% | +$1.71M | 1.15% | 16 |
|
|
2018
Q2 | $480K | Buy |
2,598
+198
| +8% | +$35K | 0.36% | 53 |
|
|
2018
Q1 | $411K | Buy |
2,400
+2,348
| +4,515% | +$431K | 0.3% | 51 |
|
|
2017
Q4 | $9K | Hold |
52
| – | – | 0.01% | 263 |
|
|
2017
Q3 | $9K | Buy |
+52
| New | +$9.21K | 0.01% | 227 |
|
|
2017
Q1 | – | Sell |
-257
| Closed | -$37K | – | 201 |
|
|
2016
Q4 | $37K | Buy |
+257
| New | +$38.7K | 0.05% | 111 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Legacy Advisors's AMGN Position: Q2 2026 in Review
Legacy Advisors reduced its Amgen (AMGN) stake by 0.18% in Q2 2026, selling an estimated $2.74K and leaving 4,387 shares worth $1.59M. The position accounts for 0.15% of the portfolio, ranked #82.
Legacy Advisors first reported a position in AMGN in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.81M in Q3 2023. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Legacy Advisors held 4,387 shares of Amgen worth $1.59M as of Q2 2026.
- Legacy Advisors sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
- Amgen made up 0.15% of Legacy Advisors's portfolio in Q2 2026, its #82 holding.
- Legacy Advisors first reported a position in Amgen in Q4 2016 and has held it in 36 quarters since.
- Legacy Advisors's Amgen position peaked at $3.81M in Q3 2023.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.